Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Health › Ex-councillor guilty of running sham Covid-19 lab
Health

Ex-councillor guilty of running sham Covid-19 lab

Ex-councillor guilty of running sham Covid-19 lab
BBC England Thursday 08 October 2026, 13:59 UTC 1 min read
Key Points

Faisal Shoukat is convicted of fraudulent trading and money laundering after a trial.

Faisal Shoukat is convicted of fraudulent trading and money laundering after a trial.
Faisal Shoukat (PERSON)
Originally published by BBC England Read original →

Related Stories

Kentucky State player released on bond after 2 months in ICE custody

A Kentucky State University women's basketball player was released on bond Wednesday after spending two months in ICE custody. Aminata Seck, 26, from Dakar, Senegal, was greeted by family members outside of the Grayson County Detention Center in Leitchfield, Kentucky. An immigration judge set Seck's $2,500 bond after determining that she is neither a danger to the community nor a flight risk, according to her attorney, Hishem Alsalman.

ESPN just now

'Slightly ominous’ sign that England could be set for an early flu season

'Slightly ominous’ sign that England could be set for an early flu season While levels of flu are currently low, figures from September have been higher than the same period for the last four years - Bookmark - CommentsGo to comments Become an Independent member to bookmark this article Already a member? Log in England could be set for an early flu season with hospital admissions at a “high” level for this time of year, according to health officials. The NHS National Medical Director,...

The Independent UK 11m ago

Christa Pike now walking after failed US execution, lawyer tells BBC

A lawyer says the murderer of Colleen Slemmer is moving around her hospital room after surviving two lethal injections.

BBC News 13m ago

J&J CEO Joaquin Duato on Obesity, Cancer and AI | The David Rubenstein Show

Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duato also talked about how artificial intelligence could accelerate drug discovery and the development of new medicines.

Bloomberg Markets 49m ago